Evidence map›Paper›PMID 23021218›Full record

ArticleCell2012

TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis.

Li Ye, Sandra Kleiner, Jun Wu, Rajan Sah, Rana K Gupta, Alexander S Banks, Paul Cohen, Melin J Khandekar, Pontus Boström, Rina J Mepani and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 1 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 1 synthesis or guideline pooled it, 339 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Li YeDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Sandra Kleiner
Jun Wu
Rajan Sah
Rana K Gupta
Alexander S Banks
Paul Cohen
Melin J Khandekar
Pontus Boström
Rina J Mepani
Dina Laznik
Theodore M Kamenecka
Xinyi Song
Wolfgang Liedtke
Vamsi K Mootha
Pere Puigserver
Patrick R Griffin
David E Clapham
Bruce M Spiegelman
Dana-Farber Cancer Institute · USHarvard University · USBoston Children's Hospital · USDuke Medical Center · USMassachusetts General Hospital · US

Funding

Chemical Biology of Mitochondria and DiabetesR24DK080261 · NIDDK · DANA-FARBER CANCER INST · PI SPIEGELMAN, BRUCE M. · 2007 to 2016
$13.9M
CONTROL OF ADIPOCYTE GENE EXPRESSION AND PHYSIOLOGYR37DK031405 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI SPIEGELMAN, BRUCE M. · 1996 to 2013
$8.2M
TRP Channel Mediated Pain CircuitryP01NS072040 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WOOLF, CLIFFORD J · 2011 to 2015
$6.7M
CONTROL OF LIPOGENIC ENZYME SYNTHESIS IN ADIPOCYTESR01DK031405 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI SPIEGELMAN, BRUCE M. · 1986 to 2018
$2.9M
Interdisciplinary Training in Genetics & Complex DiseaseR90DK071507 · NIDDK · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WESSLING-RESNICK, MARIANNE · 2004 to 2008
$1.1M
Molecular regulation of the brown-like ("beige") cells of white fat depotsK01DK094824 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WU, JUN · 2012 to 2014
$381k
NIDDK NIH HHS 5R90DK071507NIDDK NIH HHS DK031405NIDDK NIH HHS DK080261NIDDK NIH HHS K01 DK094824NIDDK NIH HHS R24 DK080261NIDDK NIH HHS R37 DK031405NIDDK NIH HHS R90 DK071507NINDS NIH HHS P01 NS072040
6 · The paper itself

Abstract

PGC1α is a key transcriptional coregulator of oxidative metabolism and thermogenesis. Through a high-throughput chemical screen, we found that molecules antagonizing the TRPVs (transient receptor potential vanilloid), a family of ion channels, induced PGC1α expression in adipocytes. In particular, TRPV4 negatively regulated the expression of PGC1α, UCP1, and cellular respiration. Additionally, it potently controlled the expression of multiple proinflammatory genes involved in the development of insulin resistance. Mice with a null mutation for TRPV4 or wild-type mice treated with a TRPV4 antagonist showed elevated thermogenesis in adipose tissues and were protected from diet-induced obesity, adipose inflammation, and insulin resistance. This role of TRPV4 as a cell-autonomous mediator for both the thermogenic and proinflammatory programs in adipocytes could offer a target for treating obesity and related metabolic diseases.

Indexed as

Energy MetabolismThermogenesisAdipocytesAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsFemaleGene Knockdown TechniquesIon ChannelsMaleMiceMice, Inbred C57BLMitochondrial ProteinsObesityPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaTrans-ActivatorsIon ChannelsMitochondrial ProteinsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseTrans-ActivatorsTranscription FactorsTrpv4 protein, mouseTRPV Cation ChannelsUcp1 protein, mouseUncoupling Protein 1

Identifiers

PMID23021218
PMCPMC3477522
OpenAlexW2007885739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.